Skip to main content
Contact Us
Subscribe
E-Edition
66°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Longboard Pharmaceuticals Inc
(NQ:
LBPH
)
19.72
+0.47 (+2.44%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Longboard Pharmaceuticals Inc
< Previous
1
2
3
Next >
Longboard Pharmaceuticals to Present Late-Breaking Data from the PACIFIC Study at the American Academy of Neurology (AAN) Annual Meeting on April 15
April 03, 2024
From
Longboard Pharmaceuticals, Inc.
Via
Business Wire
Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
April 02, 2024
From
Longboard Pharmaceuticals, Inc.
Via
Business Wire
Recap: Longboard Pharmaceuticals Q4 Earnings
March 12, 2024
Via
Benzinga
Looking Into Longboard Pharmaceuticals's Recent Short Interest
January 19, 2024
Via
Benzinga
Longboard Pharmaceuticals Reports Full Year 2023 Financial Results and Provides Corporate Updates
March 12, 2024
From
Longboard Pharmaceuticals, Inc.
Via
Business Wire
Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
March 01, 2024
From
Longboard Pharmaceuticals, Inc.
Via
Business Wire
Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
February 02, 2024
From
Longboard Pharmaceuticals, Inc.
Via
Business Wire
Longboard Pharmaceuticals to Present at Two Upcoming Investor Conferences in February
February 01, 2024
From
Longboard Pharmaceuticals, Inc.
Via
Business Wire
Why Intel Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
January 26, 2024
Shares of Intel Corporation (NASDAQ: INTC) fell sharply during Friday’s session. Intel reported upbeat results for its fourth quarter, but issued a weak forecast for the first quarter.
Via
Benzinga
Forget the "Magnificent Seven" -- This Stock Has Nearly Quadrupled in 2024, and Wall Street Thinks It Can Go a Lot Higher
January 17, 2024
You might say that this biotech stock is magnificent.
Via
The Motley Fool
Cantor Fitzgerald Maintains Overweight Rating for Longboard Pharmaceuticals: Here's What You Need To Know
January 16, 2024
Via
Benzinga
Longboard Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
January 08, 2024
From
Longboard Pharmaceuticals, Inc.
Via
Business Wire
This biotech stock has surged over 300% this week
January 05, 2024
Shares of Longboard Pharmaceuticals (NASDAQ: LBPH) have sky-rocketed higher this week, up over 300% thanks to breaking news
Via
MarketBeat
Jim Cramer: This Energy Firm Has 'Good Growth, Good Yield' But As For IonQ? Ixnay
January 04, 2024
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Equitrans Midstream Corporation (NYSE: ETRN) is very solid. "Good growth, good yield.
Via
Benzinga
Longboard Pharmaceuticals Announces Pricing of Upsized Public Offering of Common Stock
January 03, 2024
From
Longboard Pharmaceuticals, Inc.
Via
Business Wire
Why Longboard Pharmaceuticals Stock Is Falling
January 03, 2024
Longboard Pharmaceuticals Inc (NASDAQ: LBPH) shares are trading lower by 11.3% to $22.26 Wednesday afternoon after the company announced that it commenced a $150 million underwritten public offering...
Via
Benzinga
Apple, Longboard Pharmaceuticals, Coinbase, Moderna, Tesla: Why These 5 Stocks Are On Investors' Radars Today
January 02, 2024
U.S. stocks experienced mixed results in Tuesday’s trading session. The Dow Jones index showed resilience, gaining around 25 points, a modest rise of 0.07% to 37,715.04. In contrast, the tech-heavy...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Longboard Pharma Catapulted 316%, Leading A Biotech Stock Rally
January 02, 2024
Longboard Pharmaceuticals is working on treatments for seizure disorders.
Via
Investor's Business Daily
Longboard Pharmaceuticals Announces Commencement of Public Offering of Common Stock
January 02, 2024
From
Longboard Pharmaceuticals, Inc.
Via
Business Wire
Crude Oil Down 2%; Tesla Deliveries Top Estimates
January 02, 2024
U.S. stocks traded mostly lower toward the end of trading, with the Nasdaq Composite falling more than 250 points on Tuesday. The Dow traded up 0.01% to 37,691.77 while the NASDAQ fell 1.78% to...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
There's Optimism Around Longboard Pharmaceuticals' Anti-Seizure Candidate: Analyst Boosts Price Target
January 02, 2024
Tuesday, Longboard Pharmaceuticals Inc (NASDAQ: LBPH) released topline data from the PACIFIC Phase 1b/2a study evaluating bexicaserin (LP352) for seizures associated with a broad range of...
Via
Benzinga
Why Longboard Pharmaceuticals Shares Are Trading Higher By Around 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
January 02, 2024
Shares of Longboard Pharmaceuticals, Inc.
Via
Benzinga
Why Is Longboard Pharmaceuticals (LBPH) Stock Up 175% Today?
January 02, 2024
With Longboard Pharmaceuticals delivering positive clinical trial data, LBPH stock soared on the positive therapeutic implications.
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's Intraday Session
January 02, 2024
Via
Benzinga
Dow Turns Higher; Anavex Life Sciences Shares Plunge
January 02, 2024
U.S. stocks traded mixed midway through trading, with the Dow Jones index gaining around 50 points on Tuesday. The Dow traded up 0.13% to 37,739.18 while the NASDAQ fell 1.29% to 14,818.23. The S&P 500...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Neurology-Focused Longboard Pharmaceuticals' Stock Soars Over 200% Today - Here's Why
January 02, 2024
Longboard Pharmaceuticals Inc (NASDAQ: LBPH) released topline data from the PACIFIC Phase 1b/2a study evaluating bexicaserin (LP352) for seizures associated with a broad range of Developmental
Via
Benzinga
Dow Down 100 Points; US Manufacturing PMI Falls In December
January 02, 2024
U.S. stocks traded lower this morning, with the Dow Jones index falling more than 100 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.28% to 37,584.41 while the NASDAQ...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
January 02, 2024
Via
Benzinga
Longboard Pharmaceuticals Announces Positive Topline Data from the PACIFIC Study, a Phase 1b/2a Clinical Trial, for Bexicaserin (LP352) in Participants with Developmental and Epileptic Encephalopathies (DEEs)
January 02, 2024
From
Longboard Pharmaceuticals, Inc.
Via
Business Wire
Longboard Pharmaceuticals to Host Call to Discuss Topline Data from the PACIFIC Study, a Phase 1b/2a Clinical Trial for Bexicaserin (LP352) in Participants with Developmental and Epileptic Encephalopathies (DEEs)
January 01, 2024
From
Longboard Pharmaceuticals, Inc.
Via
Business Wire
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.